LLY logo

LLY

Eli Lilly and Company

$874.00
+$5.73(+0.66%)
56
Overall
45
Value
54
Tech
71
Quality
How is this score calculated?
Market Cap
$788.86B
Volume
2.56M
52W Range
$623.78 - $1,133.95
Target Price
$1,240.89
Order:

Income Statement

MetricTrendChart
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
2025
Dec
REVENUE
Total Revenue
$21.2B$22.9B$21.5B$22.3B$24.5B$28.3B$28.5B$34.1B$45.0B$65.2B
Total Revenue
$21.2B$22.9B$21.5B$22.3B$24.5B$28.3B$28.5B$34.1B$45.0B$65.2B
COST OF GOODS SOLD
Cost of Revenue
$5.7B$6.2B$4.7B$4.7B$5.5B$7.3B$6.6B$7.1B$8.4B$11.1B
GROSS PROFIT
Gross Profit
$15.6B$16.7B$16.8B$17.6B$19.1B$21.0B$21.9B$27.0B$36.6B$54.1B
OPERATING EXPENSES
Operating Expenses
$11.7B$12.0B$11.0B$11.8B$12.2B$13.4B$13.3B$20.5B$22.9B$27.3B
Research & Development
$5.2B$5.4B$5.1B$5.6B$6.1B$6.9B$8.1B$13.1B$14.3B$16.2B
Research Expense
$5.2B$5.4B$5.1B$5.6B$6.1B$6.9B$7.2B$9.3B$11.0B$13.3B
Selling, General & Administrative
$6.5B$6.7B$6.0B$6.2B$6.1B$6.4B$6.4B$7.4B$8.6B$11.1B
Selling & Marketing Expenses
----$900.0M$1.1B$1.1B$1.2B$966.8M$1.1B$1.4B--
General & Administrative Expenses
$6.5B$6.7B$6.0B$6.2B$6.1B$6.4B$6.4B$7.4B$8.6B$11.1B
Promotion & Advertising
----$900.0M$1.1B$1.1B$1.2B--------
Salaries & Wages
$-89.4M$-70.5M$-53.2M$-64.4M$-64.7M$-72.0M--------
Depreciation & Amortization
$716.2M$763.1M$797.1M$814.7M$765.2M$787.0M$816.6M$1.5B$1.8B--
Depreciation & Amortization
$716.2M$763.1M$797.1M$814.7M$765.2M$787.0M--------
Amortization
$4.4B$4.4B$1.4B$6.6B$7.5B$7.7B$7.2B$6.9B$6.2B--
Other Operating Expenses
$-73.4M$-133.8M$-798.2M$-187.2M$-225.6M$-310.3M--------
OPERATING INCOME
Operating income
$3.9B$4.7B$5.8B$5.8B$6.8B$7.6B$7.4B$6.5B$13.7B$26.8B
EBITDA
$4.9B$3.8B$5.3B$6.6B$8.9B$8.0B$8.7B$8.6B$14.4B$27.7B
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$185.2M$225.0M$242.5M$400.6M$359.6M$339.8M$331.6M$485.9M$780.6M--
Intinc
$108.7M$167.3M$159.3M$80.4M$33.0M$25.4M$62.8M$173.6M$175.2M--
Net Non-Operating Interest Income/Expense
$-76.5M$-57.7M$-83.2M$-320.2M$-326.6M$-314.4M$-268.8M$173.6M$-605.4M--
Gain on Sale of Securities
$30.7M$176.0M$20.1M$-401.2M$1.4B$176.9M$-410.7M$-20.2M$-49.5M--
Other Income/Expense
$84.8M$-300.5M$-145.6M$-291.6M$-1.2B$201.6M$-1.6B$-96.7M$219.0M$571.0M
Other Special Charges
$-84.8M$300.5M$145.6M$291.6M$1.2B$-201.6M$-320.9M$96.7M$-219.0M$-571.0M
SPECIAL ITEMS
Restructring And Mn A Income
$382.5M$1.7B$266.9M$575.6M$131.2M$316.1M$244.6M$67.7M$861.0M$484.0M
Special Income Charges
$-382.5M$-1.7B$-266.9M$-575.6M$-131.2M$-316.1M$-244.6M$-67.7M$-861.0M$-484.0M
Other Impairment Of Capital Assets
$53.0M$50.0M------$108.1M--------
PRE-TAX INCOME
EBIT
$3.4B$2.2B$3.7B$5.4B$7.6B$6.5B$7.1B$7.0B$12.7B$25.7B
Pre-Tax Income
$3.4B$2.2B$3.7B$5.3B$7.2B$6.2B$6.8B$6.6B$12.7B$25.7B
INCOME TAX
Tax Provision
$636.4M$2.4B$529.5M$628.0M$1.0B$573.8M$561.6M$1.3B$2.1B$5.1B
NET INCOME
Net Income
$2.7B$-204.1M$3.2B$8.3B$6.2B$5.6B$6.2B$5.2B$10.6B$20.6B
Net Income (Continuing Operations)
$2.7B$-204.1M$3.2B$8.3B$6.2B$5.6B$6.2B$5.2B$10.6B$20.6B
Net Income (Discontinued Operations)
$2.7B$-204.1M$3.2B$8.3B$6.2B$5.6B$6.2B$5.2B$10.6B$20.6B
Net Income (Common Stockholders)
$2.8B$908.5M$5.2B$8.6B$6.2B$5.6B$6.2B$5.2B$10.6B$20.6B
Normalized Income
$2.9B$3.3B$3.2B$1.1B$5.8B--------$26.0B
TOTALS
Total Expenses
$17.4B$18.2B$15.7B$16.5B$17.7B$20.7B$19.9B$27.6B$31.3B$38.4B
SHARE & EPS DATA
Average Shares Outstanding
$1.1B$1.1B$1.0B$931.1M$907.6M$907.0M$901.7M$900.2M$900.6M$897.3M
Average Shares Outstanding (Diluted)
$1.1B$1.1B$1.0B$935.7M$912.5M$911.7M$904.6M$903.3M$904.1M$899.3M
Shares Outstanding
$1.1B$1.1B$1.0B$956.4M$958.4M$952.3M$950.3M$950.2M$948.2M$943.4M
Basic EPS
$2.59$-0.19$3.14$8.93$6.82$6.15$6.93$5.82$11.76$23
Basic EPS (Continuing Operations)
$2.59$-0.19$3.14$4.98$6.82$6.15$6.93$5.82$11.76$23
Diluted EPS
$2.58$-0.19$3.13$8.89$6.79$6.12$6.9$5.8$11.71$22.95
Diluted EPS (Continuing Operations)
$2.58$-0.19$3.13$4.96$6.79$6.12$6.9$5.8$11.71$22.95
Dividend Per Share
$2.04$2.25$2.58$2.6$2.96$3.4$3.92$4.52$5.4$6.23
OTHER METRICS
Basic Discontinuous Operations
------$3.95------------
Development Expense
------------$908.5M$3.8B$3.3B$2.9B
Diluted Discontinuous Operations
------$3.93------------
Earnings from equity interest
$-2.2B$-2.2B----------------
Earnings From Equity Interest Net Of Tax
$-2.2B$-2.2B----------------
Gain On Sale Of Business
------$3.7B------------
Gains Loss On Disposal Of Discontinued Operations
------$309.8M------------
Interest Expense Operating
$-146.4M$-192.7M$-223.8M$-305.5M$-345.8M$-338.0M--------
Minority Interests
$14.1B$11.7B$10.9B$2.7B$5.8B----------
Net Income Discontinuous Operations
----$81.4M$3.7B------------
Other Gain Loss From Disposition Of Discontinued Operations
----$81.4M$3.7B------------
Other Gand A
$6.5B$6.7B$6.0B$6.2B$6.1B$6.4B$6.4B$7.4B$8.6B$11.1B
Rent And Landing Fees
$221.0M$224.5M$175.7M--------------
Restruct
$382.5M$1.7B$266.9M$575.6M$131.2M$316.1M$244.6M$67.7M$861.0M$484.0M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2LLY$874.00+0.7%2.56M
3
4
5
6

Get Eli Lilly and Company Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.